Skip to main navigation Skip to search Skip to main content

Targeting Myeloid-Derived Suppressor Cells (MDSCs) and Tumour-Associated Macrophages (TAMs) with the anti-CD33 immunotoxin Gemtuzumab ozogamicin to restore anti-cancer immunuity

Project Details

Short titleTargeting Myeloid-Derived Suppressor Cells (MDSCs) and Tumour-Associated Macrophages (TAMs) with the anti-CD33 immunotoxin Gemtuzumab ozogamicin to restore anti-cancer immunuity
StatusFinished
Effective start/end date1/06/19 → 30/11/20

Funding

  • Children's Cancer And Leukaemia Group